| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/GLIA.22504 |
| P698 | PubMed publication ID | 23832579 |
| P2093 | author name string | Beverly Bealmear | |
| Joyce A Benjamins | |||
| Robert P Lisak | |||
| Liljana Nedelkoska | |||
| P2860 | cites work | Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis | Q28212804 |
| Glutamate and multiple sclerosis | Q28258908 | ||
| Induction of a Common Pathway of Apoptosis by Staurosporine | Q29042381 | ||
| Multiple sclerosis | Q29616022 | ||
| Stress and the brain: from adaptation to disease | Q29619381 | ||
| Brain corticosteroid receptor balance in health and disease | Q29620564 | ||
| The current evaluation and treatment of infantile spasms among members of the Child Neurology Society | Q30455995 | ||
| Binding of cholera toxin B subunit: a surface marker for murine microglia but not oligodendrocytes or astrocytes | Q32027913 | ||
| Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis | Q32065766 | ||
| Non-N-methyl-D-aspartate glutamate receptors mediate oxygen--glucose deprivation-induced oligodendroglial injury | Q33180241 | ||
| Acute NMDA toxicity in cultured rat cerebellar granule neurons is accompanied by autophagy induction and late onset autophagic cell death phenotype | Q33532294 | ||
| NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia | Q33565598 | ||
| Intravenous methylprednisolone for multiple sclerosis in relapse | Q33620748 | ||
| Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling | Q33792422 | ||
| Melanocortins and the treatment of nervous system disease. Potential relevance to the skin? | Q33921707 | ||
| Glycolipids and transmembrane signaling: antibodies to galactocerebroside cause an influx of calcium in oligodendrocytes | Q33928786 | ||
| Glucocorticoid protection of oligodendrocytes against excitotoxin involving hypoxia-inducible factor-1alpha in a cell-type-specific manner. | Q34125992 | ||
| Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection | Q34247391 | ||
| Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress | Q34337582 | ||
| Brain effects of melanocortins. | Q34599982 | ||
| Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders | Q34653971 | ||
| Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases | Q34675057 | ||
| The developing oligodendrocyte: key cellular target in brain injury in the premature infant | Q34995998 | ||
| Validation of the rat model of cryptogenic infantile spasms. | Q35204574 | ||
| Growth requirements in vitro of oligodendrocyte cell lines and neonatal rat brain oligodendrocytes | Q35596332 | ||
| Targeting melanocortin receptors as a novel strategy to control inflammation. | Q35682900 | ||
| Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures. | Q51586474 | ||
| Postnatal expression of melanocortin-3 receptor in rat diencephalon and mesencephalon. | Q52196350 | ||
| Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice. | Q54363020 | ||
| The melanocortin system in control of inflammation. | Q55426694 | ||
| Contrasting potential of nitric oxide and peroxynitrite to mediate oligodendrocyte injury in multiple sclerosis | Q57041843 | ||
| Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis | Q57416513 | ||
| Glutamate excitotoxicity in a model of multiple sclerosis | Q60450917 | ||
| Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS | Q69351477 | ||
| Expression of melanocortin 1 receptor in periaqueductal gray matter | Q70986697 | ||
| Solubilisation partial characterisation of the alpha-MSH receptor on primary rat Schwann cells | Q72659471 | ||
| Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis | Q73270591 | ||
| Cyclic GMP-dependent pathways protect differentiated oligodendrocytes from multiple types of injury | Q79453321 | ||
| Ingested (oral) alpha-MSH inhibits acute EAE | Q79968706 | ||
| Same players, different game: AMPA receptor regulation in oligodendrocyte progenitors | Q82221469 | ||
| Ingested (oral) ACTH inhibits EAE | Q82472688 | ||
| Oral ACTH (H.P. Acthar(®)Gel) inhibits IL-1 and IL-17 secretion in humans | Q83242173 | ||
| Cytokines reduce toxic effects of ethanol on oligodendroglia | Q83327219 | ||
| Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development | Q36112101 | ||
| Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside | Q36292898 | ||
| Nitric oxide synthase expression and nitric oxide toxicity in oligodendrocytes | Q36505638 | ||
| Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology | Q36606100 | ||
| Excitotoxic damage to white matter. | Q36822954 | ||
| Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures | Q37091141 | ||
| Glutamatergic signaling in the brain's white matter. | Q37100000 | ||
| The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection | Q37408458 | ||
| Distribution and function of melanocortin receptors within the brain | Q37827455 | ||
| Glutamate and ATP signalling in white matter pathology | Q37830727 | ||
| Treatment of infantile spasms: emerging insights from clinical and basic science perspectives | Q37896402 | ||
| Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery | Q37972998 | ||
| Corticosteroids for the treatment of infantile spasms: a systematic review | Q38031818 | ||
| Staurosporine-induced apoptosis of cultured rat hippocampal neurons involves caspase-1-like proteases as upstream initiators and increased production of superoxide as a main downstream effector. | Q39476761 | ||
| Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter | Q40315187 | ||
| Signaling mechanisms controlled by melanocortins in melanoma, lacrimal, and brain astroglial cells | Q40855157 | ||
| Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture | Q40925821 | ||
| Alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma | Q40929097 | ||
| Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. | Q41035747 | ||
| Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity. | Q41039902 | ||
| Melanocortin analogue Org2766 binds to rat Schwann cells, upregulates NGF low-affinity receptor p75, and releases neurotrophic activity | Q41398478 | ||
| Cerebral white matter contains PDGF-responsive precursors to O2A cells | Q41731670 | ||
| Characterization of specific binding sites for [3H]-staurosporine on various protein kinases | Q41785129 | ||
| Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins | Q41825402 | ||
| The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy | Q41975249 | ||
| Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase | Q42216028 | ||
| Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway | Q42492353 | ||
| The receptor subunits generating NMDA receptor mediated currents in oligodendrocytes | Q42957371 | ||
| A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS. | Q43233446 | ||
| Oligodendrocyte killing by quinolinic acid in vitro | Q43558984 | ||
| Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage | Q43708042 | ||
| Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside | Q43899714 | ||
| Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity | Q44263018 | ||
| Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis | Q44477073 | ||
| Treatment of cerebral ischemia with melanocortins acting at MC4 receptors induces marked neurogenesis and long-lasting functional recovery | Q44880939 | ||
| Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms | Q45018878 | ||
| The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis | Q45081500 | ||
| Functional glutamate transport in rodent optic nerve axons and glia. | Q45904559 | ||
| Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. | Q46083107 | ||
| Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis | Q46609780 | ||
| Action of adrenocorticotropic hormone (ACTH) in experimental allergic encephalomyelitis of the guinea pig. | Q46889143 | ||
| Alpha-MSH rescues neurons from excitotoxic cell death | Q46938298 | ||
| Glutamate receptor expression in multiple sclerosis lesions | Q46959335 | ||
| Alpha-MSH inhibits inflammatory signalling in Schwann cells. | Q47740805 | ||
| Redistribution and internalization of antibodies to galactocerebroside by oligodendroglia | Q48104091 | ||
| Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes | Q48124765 | ||
| Effective use of a neurotrophic ACTH4-9 analogue in the treatment of a peripheral demyelinating syndrome (experimental allergic neuritis). An intervention study | Q48142711 | ||
| Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention | Q48316824 | ||
| Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells. | Q48374865 | ||
| Melanocortins stimulate proliferation and induce morphological changes in cultured rat astrocytes by distinct transducing mechanisms | Q48506174 | ||
| Secretory products of central nervous system glial cells induce Schwann cell proliferation and protect from cytokine-mediated death. | Q50480296 | ||
| P433 | issue | 8 | |
| P921 | main subject | inflammation | Q101991 |
| neuroglia | Q177105 | ||
| excitotoxicity | Q901117 | ||
| oligodendrocyte | Q916698 | ||
| P304 | page(s) | 1206-1217 | |
| P577 | publication date | 2013-07-05 | |
| P1433 | published in | Glia | Q15716658 |
| P1476 | title | ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro | |
| P478 | volume | 61 |
| Q89736123 | Activation of Melanocortin-4 Receptor Inhibits Both Neuroinflammation Induced by Early Exposure to Ethanol and Subsequent Voluntary Alcohol Intake in Adulthood in Animal Models: Is BDNF the Key Mediator? |
| Q54116484 | Activation of melanocortin receptor 4 with RO27-3225 attenuates neuroinflammation through AMPK/JNK/p38 MAPK pathway after intracerebral hemorrhage in mice. |
| Q27319946 | Attention deficit associated with early life interictal spikes in a rat model is improved with ACTH |
| Q47175603 | Deficiency of leptin receptor in myeloid cells disrupts hypothalamic metabolic circuits and causes body weight increase |
| Q41995287 | Dock3 protects myelin in the cuprizone model for demyelination |
| Q46932015 | Effects of dextromethorphan on glial cell function: proliferation, maturation, and protection from cytotoxic molecules |
| Q34381234 | Excitotoxic brain injury in adult zebrafish stimulates neurogenesis and long-distance neuronal integration |
| Q38756563 | Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms |
| Q26865343 | Melanocortin peptides: potential targets in systemic lupus erythematosus |
| Q46311295 | Melanocortin receptor subtypes are expressed on cells in the oligodendroglial lineage and signal ACTH protection. |
| Q41552761 | Melanocortins, Melanocortin Receptors and Multiple Sclerosis |
| Q37737604 | New Implications for the Melanocortin System in Alcohol Drinking Behavior in Adolescents: The Glial Dysfunction Hypothesis. |
Search more.